# A Study to Assess the Absolute Bioavailability and How Adimanebart SC Moves Through the Body in Healthy Adult Participants

> **NCT07673601** · PHASE1 · RECRUITING · sponsor: **argenx** · enrollment: 52 (estimated)

## Conditions studied

- Healthy Volunteers (HV)
- Healthy Volunteer

## Interventions

- **BIOLOGICAL:** Adimanebart IV
- **BIOLOGICAL:** Adimanebart SC - formulation A
- **BIOLOGICAL:** Adimanebart SC - formulation B
- **BIOLOGICAL:** Adimanebart SC - formulation C

## Key facts

- **NCT ID:** NCT07673601
- **Lead sponsor:** argenx
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-12
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 52 (ESTIMATED)
- **Last updated:** 2026-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07673601

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07673601, "A Study to Assess the Absolute Bioavailability and How Adimanebart SC Moves Through the Body in Healthy Adult Participants". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07673601. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*